 |
|
 |
 |

Home > Company Index > Drugs > Drug Manufacturers - Other > Forest Laboratories, Inc.
 |
Forest Laboratories, Inc. |
 |
 |
 |
NEWS FROM THE WIRES |
 |
RESEARCH ALERT-Lehman ups Forest Labs estimates Jul 18 2001 08:58 AM PDT
Hong Kong Hot Stocks-Legend down on U.S. tech woes Jul 18 2001 12:45 AM PDT
Forest Labs profits more than double on Celexa Jul 17 2001 05:44 AM PDT
Forest Labs profits more than double on Celexa Jul 17 2001 05:44 AM PDT
> More WIRE STORIES about this company
PROFILE |
 |
Forest Laboratories is generic no more. The company develops and manufactures name-brand as well as generic prescription and nonprescription pharmaceutical products. The company's pharmaceutical line includes Celexa, an antidepressant that accounts for nearly half of total sales; hypertension drug Tiazac (about 20%); Infasurf, which treats respiratory distress syndrome in premature infants; and Cervidil, a gel used to help speed the birthing process. Forest Laboratories, which has subsidiaries in the UK and Ireland, markets directly to doctors, drugstore chains, managed care organizations, and distributors through its own sales force.
COMPETITION |
 |
Eli Lilly and Company (LLY)
GlaxoSmithKline plc (GSK)
Pfizer Inc (PFE)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: March
2001 Sales (mil.): 1,174.50
1-Yr. Sales Growth: 33.2%
Employees: 2,826
Revenue per employee: $415,605.10
KEY PEOPLE |
 |
Howard Solomon
CEO
John E. Eggers
CFO
CONTACT INFO |
 |
909 3rd Ave.
New York, NY 10022
US
Phone: 212-421-7850
Fax: 212-750-9152
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |